In CKD, once-daily empagliflozin reduced progression of kidney disease or CV death at 2 y.
作者信息
Kwong Y Diana, Hsu Chi-Yuan
机构信息
University of California, San Francisco, San Francisco, California, USA (Y.D.K., C.H.).
出版信息
Ann Intern Med. 2023 Mar;176(3):JC26. doi: 10.7326/J23-0009. Epub 2023 Mar 7.
DOI:10.7326/J23-0009
PMID:36877974
Abstract
EMPA-KIDNEY Collaborative Group; Herrington WG, Staplin N, Wanner C, et al. N Engl J Med. 2023;388:117-27. 36331190.
摘要
Zotero 插件